Reincisol
ISSN 2953-6421 · active 2022–2026
We hold limited data for this venue — no reliable citation rate or index membership — so this page is intentionally excluded from search engines. Treat what follows as partial.
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Is this the right journal for your paper?
The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.
Indexing & access
No index membership recorded in our data for DOAJ, Scopus, Web of Science, PubMed, TR Dizin, or SciELO. Verify each directly.
Access status: gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Reincisol a predatory journal?
Our screening does not flag Reincisol. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. We hold no index-membership record for it, so verify independently.
Is Reincisol indexed in Scopus or Web of Science?
We hold no index-membership record for Reincisol in DOAJ, Scopus, Web of Science, PubMed, TR Dizin, or SciELO. Absence in our data is not proof of absence from those indexes; check each directly.
What is the impact factor of Reincisol?
Papers in Reincisol are cited about 0.4 times each within two years of publication, with an h-index of 7. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.
Is Reincisol open access?
Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
Ready to submit? Tools for your next paper
Similar venues
- Progress in Materials ScienceQ1 · Elsevier BV
- Pharmacological ReviewsQ1 · American Society for Pharmacology and Experimental Therapeutics
- Materials Science and Engineering R ReportsQ1 · Elsevier BV
- British Journal of Educational TechnologyQ1 · Wiley
- Physics ReportsQ1 · Elsevier BV
- Drug Resistance UpdatesQ1 · Elsevier BV